SLC7A11 and lung cancer: xCT-overexpressing lung cancer cells are more sensitive to glutamine withdrawal compared to xCT-knockdown cells and show a less invasive phenotype in the absence of glutamine, indicating that glutaminolysis becomes an essential metabolic pathway in the presence of high xCT levels.